Fetal Bovine Serum market Research Report, by Product Type (Charcoal Stripped, Exosome Depleted, Stem Cell), by Application (Drug Discovery, Cell Culture Media, In-Vitro Fertilization), by End User (Pharmaceutical, Biotechnology) – Global Forecast Till 2027
ID: MRFR/HC/5908-HCR | February 2021 | Region: Global | 110 pages
Market Scenario
The global fetal bovine serum market is projected to grow significantly over the forecast period. It is estimated that the global fetal bovine serum market is expected to register a CAGR of ~8% during the forecast period of 2018–2023. Fetal bovine serum, a by-product of the beef industry is a crucial raw material for animal health, biotechnology, pharmaceutical research, and diagnostic as well as other research areas.
The advancement in research and academic initiatives by the private and governmental sector is expected to drive the market growth. Further, the increase in demand from traditional users of serum is also expected to drive the growth of the market. As fetal bovine serum has higher efficiency rate than normal blood serum it is expected to boost the growth of the overall serum market. Decrease in cattle herd population due to the increased demand of dairy and meat products is expected to restrain the market growth.
Segmentation
The global fetal bovine serum market is segmented on the basis of product type, application, and end user.
The fetal bovine serum market, by product type is categorised into Charcoal Stripped, Chromatographic
Dialyzed Fetal Bovine Serum (FBS), Exosome Depleted, Stem Cell, and others. Further, the stem cell segment is divided into embryonic stem cells qualified, and mesenchymal stem cell qualified.
Based on application, the fetal bovine serum market is segmented into drug discovery, cell culture media, in-vitro fertilization, human & animal vaccine production, diagnostics, and others.
On the basis of end user, the market is segmented into research & academic institutes, pharmaceutical, biotechnology, and others.
On the basis of region, the global fetal bovine serum market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and Latin America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific. The fetal bovine serum market in the Middle East and Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Global Fetal Bovine Serum Market Share (%), by Region, 2017
Sources: Centers for Disease Control and Prevention (CDC), US Department of Health and Human Services, National Institutes of Health
It is projected that the Americas dominated the global fetal bovine serum market owing to the growth of the market in the North American region. This is largely attributed to the factors such as increase in research funding, and growing awareness about the high-end fetal bovine serum among medical professionals.
Europe is currently holding a considerable amount of market share in the fetal bovine serum market. In near future, the region is predicted to exhibit declined growth due to ethical issues and religious sentiments pertaining to animal-derived products which will result in low market share over the forecast period.
Asia-Pacific was projected to be the fastest growing region for the global fetal bovine serum market. This owes to the infrastructural development and increase in outsourcing of research activities to the contract research organizations (CROs) at relatively low cost in this region.
The Middle East and Africa holds the least share in the global fetal bovine serum market due to the presence of economically diverse countries, and less initiatives taken by the government.
Global Fetal Bovine Serum Market, by Product type
- Charcoal Stripped
- Chromatographic
- Dialyzed Fetal Bovine Serum (FBS)
- Exosome Depleted
- Stem Cell
- Embryonic Stem Cells Qualified
- Mesenchymal Stem Cell Qualified
- Others
Global Fetal Bovine Serum Market, by Application
- Drug Discovery
- Cell Culture Media
- In Vitro Fertilization
- Human & Animal Vaccine Production
- Diagnostics
- Others
Global Fetal Bovine Serum Market, by End User
- Research & Academic Institutes
- Pharmaceutical
- Biotech
- Others
Global Fetal Bovine Serum Market, by Region
- Americas
- North America
- US
- Canada
- Latin America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- The Middle East & Africa
- Middle East
- Africa
Global Fetal Bovine Serum Market, Key Players
- HiMedia Laboratories
- Merck KGaA
- Bovogen Biologicals Pty Ltd
- Atlanta Biologicals Inc.
- TCS Biosciences Ltd
- Tissue Culture Biologicals
- Rocky Mountain Biologicals
- GE Healthcare
- Thermo Fisher Scientific
- Bio-Techne
- PAN-Biotech
- Access Biologicals
- Animal Technologies Inc.
- Nucleus Biologics
- Biological Industries
- Corning Incorporated,
Intended Audience
- Biopharmaceutical companies
- Government institutions
- Research and Development (R&D) companies
- Medical research laboratories
Frequently Asked Questions (FAQ) :
Fetal bovine serum market is projected to grow at an 8% CAGR between 2018-2023.
The Americas is expected to lead the fetal bovine serum market.
Product shortage may limit the fetal bovine serum market.
Major applications of the fetal bovine serum market include diagnostics, drug discovery, in-vitro fertilization, and others.
Decrease in cattle herd population may limit the fetal bovine serum market.
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Overview
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
Chapter 6. Global Fetal Bovine Serum Market, by Product type
6.1 Overview
6.2 Charcoal Stripped
6.3 Chromatographic
6.4 Dialyzed Fetal Bovine Serum (FBS)
6.5 Exosome Depleted
6.6 Stem Cell
6.6.1 Embryonic Stem Cells Qualified
6.6.2 Mesenchymal Stem Cell Qualified
6.7 Others
Chapter 7. Global Fetal Bovine Serum Market, by Application
7.1 Overview
7.2 Drug Discovery
7.3 Cell Culture Media
7.4 In Vitro Fertilization
7.5 Human & Animal Vaccine Production
7.6 Diagnostics
7.7 Others
Chapter 8. Global Fetal Bovine Serum Market, by End User
8.1 Introduction
8.2 Research & Academic Institutes
8.3 Pharmaceutical
8.4 Biotech
8.5 Others
Chapter 9. Global Fetal Bovine Serum Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 Latin America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
Chapter 11. Company Profiles
11.1 HiMedia Laboratories
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Merck KGaA
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Bovogen Biologicals Pty Ltd
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Atlanta Biologicals Inc.
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 TCS Biosciences Ltd
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Tissue Culture Biologicals
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Rocky Mountain Biologicals
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 GE Healthcare
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Thermo Fisher Scientific
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Bio-Techne
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 PAN-Biotech
11.11.1 Overview
11.11.2 Product Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Others
Chapter 12. Appendix
LIST OF TABLES
Table 1 Global Fetal bovine serum Market Synopsis, 2020-2027
Table 2 Global Fetal bovine serum Market Estimates and Forecast, 2020-2027 (USD Million)
Table 3 Global Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 4 Global Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 5 Global Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 6 Global Fetal bovine serum Market, by Region, 2020-2027(USD Million)
Table 7 North America: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 8 North America: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 9 North America: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 10 North America: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 11 US: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 12 US: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 13 US: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 14 US: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 15 Canada: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 16 Canada: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 17 Canada: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 18 Canada: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 19 South America: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 20 South America: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 21 South America: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 22 South America: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 23 Europe: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 24 Europe: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 25 Europe: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 26 Europe: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 27 Western Europe: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 28 Western Europe: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 29 Western Europe: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 30 Western Europe: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 31 Eastern Europe: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 32 Eastern Europe: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 33 Eastern Europe: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 34 Eastern Europe: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 35 Asia-Pacific: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 36 Asia-Pacific: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 37 Asia-Pacific: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 38 Asia-Pacific: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
Table 39 Middle East & Africa: Fetal bovine serum Market, by Product Type, 2020-2027 (USD Million)
Table 40 Middle East & Africa: Fetal bovine serum Market, by Application, 2020-2027 (USD Million)
Table 41 Middle East & Africa: Fetal bovine serum Market, by End User, 2020-2027 (USD Million)
Table 42 Middle East & Africa: Fetal bovine serum Market, by Region, 2020-2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Fetal bovine serum Market
Figure 3 Market Dynamics for Global Fetal bovine serum Market
Figure 4 Global Fetal bovine serum Market Share, by Product type, 2020 (%)
Figure 5 Global Fetal bovine serum Market Share, by Application, 2020 (%)
Figure 6 Global Fetal bovine serum Market Share, by End User, 2020 (%)
Figure 7 Global Fetal bovine serum Market Share, by Region, 2020 (%)
Figure 8 North America: Fetal bovine serum Market Share, by Country, 2020 (%)
Figure 9 Europe: Fetal bovine serum Market Share, by Country, 2020 (%)
Figure 10 Asia-Pacific: Fetal bovine serum Market Share, by Country, 2020 (%)
Figure 11 Middle East & Africa: Fetal bovine serum Market Share, by Country, 2020 (%)
Figure 12 Global Fetal bovine serum Market: Company Share Analysis, 2020 (%)
Figure 13 HiMedia Laboratories: Key Financials
Figure 14 HiMedia Laboratories: Segmental Revenue
Figure 15 HiMedia Laboratories: Geographical Revenue
Figure 16 Merck KGaA: Key Financials
Figure 17 Merck KGaA: Segmental Revenue
Figure 18 Merck KGaA: Geographical Revenue
Figure 19 Bovogen Biologicals Pty Ltd: Key Financials
Figure 20 Bovogen Biologicals Pty Ltd: Segmental Revenue
Figure 21 Bovogen Biologicals Pty Ltd: Geographical Revenue
Figure 22 Biomerics: Key Financials
Figure 23 Biomerics: Segmental Revenue
Figure 24 Biomerics: Geographical Revenue
Figure 25 TCS Biosciences Ltd: Key Financials
Figure 26 TCS Biosciences Ltd: Segmental Revenue
Figure 27 TCS Biosciences Ltd: Geographical Revenue
Figure 28 Tissue Culture Biologicals: Key Financials
Figure 29 Tissue Culture Biologicals: Segmental Revenue
Figure 30 Tissue Culture Biologicals: Geographical Revenue
Figure 31 Rocky Mountain Biologicals: Key Financials
Figure 32 Rocky Mountain Biologicals: Segmental Revenue
Figure 33 Rocky Mountain Biologicals: Geographical Revenue
Figure 34 GE Healthcare: Key Financials
Figure 35 GE Healthcare: Segmental Revenue
Figure 36 GE Healthcare: Geographical Revenue
Figure 37 Thermo Fisher Scientific: Key Financials
Figure 38 Thermo Fisher Scientific: Segmental Revenue
Figure 39 Thermo Fisher Scientific: Geographical Revenue
Figure 40 Bio-Techne: Key Financials
Figure 41 Bio-Techne: Segmental Revenue
Figure 42 Bio-Techne: Geographical Revenue
Figure 43 PAN-Biotech: Key Financials
Figure 44 PAN-Biotech: Segmental Revenue
Figure 45 PAN-Biotech: Geographical Revenue
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.